Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K

Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

Hope S. Rugo, MD

Date of Release

May 14th, 2025